Small Size, Big Prize

Small Size, Big Prize

An esteemed panel of marketers from small biotech companies discusses the unique challenges and opportunities of bringing novel products to market. James Chase moderates the session

Adding Value

Adding Value

With pharma transforming more rapidly than ever, seven industry vets chart a road map for meeting a changed industry's challenges. James Chase led the discussion.

If We Could Start Over...

If We Could Start Over...

Pharma marketing is not without its flaws. Last month, seven seasoned industry execs discussed what they might change if they had a clean slate. James Chase kept the peace.

Are We Patient-Centric?

Are We Patient-Centric?

Industry experts discuss what it means to truly put patients first, where pharma often falls short and what can be done to rectify this. James Chase chairs the debate

Issues with Co-Pay

Issues with Co-Pay

Co-pay initiatives rank among the most hotly debated topics in healthcare marketing today. Pharmas and healthcare providers love them. Payers and PBMs... not so much. Why is that? James Chase takes the moderator's chair

Do We Need Reps?

Do We Need Reps?

Seven industry experts evaluate advances and opportunities in non-personal promotion to physicians, and debate whether brands really need to deploy sales forces. James Chase chairs the discussion

3 Screens, 1 HCP

3 Screens, 1 HCP

Seven digital healthcare experts discuss how to turn engaging content across multiple screens into meaningful brand experiences for HCP audiences. James Chase moderates

Pact With the Payer

Pact With the Payer

How can Marketing and Managed Markets evolve an already complex relationship to meet the new demands of payers? Our expert panel, led by James Chase, has plenty of candid suggestions

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Who Needs a Gold Watch, Anyway?

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.